• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Stocks That Hit 52-Week Lows On Friday

    12/2/22 10:57:24 AM ET
    $AIP
    $AKAN
    $ASAN
    $ATIP
    Semiconductors
    Technology
    Medicinal Chemicals and Botanical Products
    Health Care
    Get the next $AIP alert in real time by email

     

    On Friday, 72 companies hit new 52-week lows.

    Interesting Points From Today's 52-Week Lows:

    • Lucid Gr (NASDAQ:LCID) is the largest company in terms of market cap to set a new 52-week low this morning.
    • Baudax Bio (NASDAQ:BXRX) was the smallest, in terms of market cap, to set a new 52-week low.
    • Eloxx Pharmaceuticals (NASDAQ:ELOX) was the biggest loser of the morning session, as it dropped 3689.14% to reach its new 52-week low.
    • Charles & Colvard (NASDAQ:CTHR)'s stock made the biggest bounce back, actually moving up 0.0% shortly after hitting a new 52-week low.

    Here is a list of stocks that set new 52-week lows on Friday:

    • Lucid Gr (NASDAQ:LCID) stock achieved a new 52-week low on Friday morning, hitting $9.55 and moving down 0.81%.
    • Asana (NYSE:ASAN) stock hit a yearly low of $15.20. The stock was down 10.5% for the day.
    • ZIM Integrated Shipping (NYSE:ZIM) stock hit a yearly low of $19.21. The stock was down 1.94% for the day.
    • Farfetch (NYSE:FTCH) stock achieved a new 52-week low on Friday morning, hitting $5.25 and moving up 7.38%.
    • Novavax (NASDAQ:NVAX) stock drifted down 6.11% on Friday morning to hit a new 52-week low of $15.53.
    • Sally Beauty Holdings (NYSE:SBH) shares hit a yearly low of $11.24. The stock was up 0.62% on the session.
    • Schrodinger (NASDAQ:SDGR) shares set a new 52-week low of $16.72. The stock traded down 3.63%.
    • ModivCare (NASDAQ:MODV) shares set a new 52-week low of $73.06. The stock traded up 0.7%.
    • B&G Foods (NYSE:BGS) shares were up 1.38% for the day, having made a 52-week low of $12.17.
    • Designer Brands (NYSE:DBI) stock broke to a new 52-week low of $10.96 on Friday. Shares of the company traded down 3.41%.
    • G-III Apparel Group (NASDAQ:GIII) stock set a new 52-week low of $11.60 on Friday, moving up 1.92%.
    • Broadmark Realty Capital (NYSE:BRMK) stock hit a new 52-week low of $3.87. The stock was down 1.61% on the session.
    • CinCor Pharma (NASDAQ:CINC) stock dropped to a yearly low on Friday of $11.41. Shares traded down 5.48%.
    • Despegar.com (NYSE:DESP) stock set a new 52-week low of $5.01 on Friday, moving down 1.33%.
    • KNOT Offshore Partners (NYSE:KNOP) shares fell to $9.36 on Friday, setting a new 52-week low with a shift of down 8.53%.
    • InterPrivate II Acq (NYSE:IPVA) stock broke to a new 52-week low of $8.70 on Friday. Shares of the company traded down 11.39%.
    • Stoke Therapeutics (NASDAQ:STOK) shares were down 0.2% for the day, having made a 52-week low of $7.02.
    • Lands' End (NASDAQ:LE) stock hit a yearly low of $7.56. The stock was down 2.3% for the day.
    • Sify Technologies (NASDAQ:SIFY) shares hit a yearly low of $1.34. The stock was up 1.1% on the session.
    • Beachbody Co (NYSE:BODY) shares moved up 0.01% on Friday to hit a new 52-week low of $0.68, drifting up 0.01%.
    • Markforged Holding (NYSE:MKFG) shares set a new yearly low of $1.10 this morning. The stock was up 1.82% on the session.
    • Instil Bio (NASDAQ:TIL) shares set a new 52-week low of $1.19. The stock traded down 3.17%.
    • Sema4 Holdings (NASDAQ:SMFR) stock broke to a new 52-week low of $0.38 on Friday. Shares of the company traded up 1.23%.
    • NGL Energy Partners (NYSE:NGL) shares set a new yearly low of $1.13 this morning. The stock was up 0.43% on the session.
    • Arteris (NASDAQ:AIP) stock dropped to a yearly low on Friday of $4.47. Shares traded down 7.02%.
    • Eagle Bancorp Montana (NASDAQ:EBMT) stock set a new 52-week low of $17.38 on Friday, moving up 0.22%.
    • First Northwest Bancorp (NASDAQ:FNWB) shares hit a yearly low of $14.22. The stock was down 2.6% on the session.
    • Summit Therapeutics (NASDAQ:SMMT) shares reached a new 52-week low of $0.66 on Friday morning, moving up 2.76%.
    • Mallinckrodt (AMEX:MNK) shares made a new 52-week low of $10.47 on Friday. The stock was down 1.68% for the day.
    • Relmada Therapeutics (NASDAQ:RLMD) stock drifted down 2.28% on Friday morning to hit a new 52-week low of $4.34.
    • VBI Vaccines (NASDAQ:VBIV) stock hit $0.50 on Friday morning, setting a new 52-week low for a change of down 0.55%.
    • Theratechnologies (NASDAQ:THTX) shares made a new 52-week low of $1.26 on Friday. The stock was down 36.49% for the day.
    • Tattooed Chef (NASDAQ:TTCF) stock set a new 52-week low of $1.34 on Friday, moving down 3.55%.
    • Grove Collaborative Hldgs (NYSE:GROV) shares reached a new 52-week low of $0.59 on Friday morning, moving down 5.34%.
    • Xos (NASDAQ:XOS) stock set a new 52-week low of $0.56 on Friday, moving down 4.76%.
    • ATI Physical Therapy (NYSE:ATIP) shares made a new 52-week low of $0.36 on Friday. The stock was down 0.52% for the day.
    • Jianzhi Education Tech (NASDAQ:JZ) stock hit $1.20 on Friday morning, setting a new 52-week low for a change of down 4.69%.
    • SmileDirectClub (NASDAQ:SDC) shares moved down 4.12% on Friday to hit a new 52-week low of $0.56, drifting down 4.12%.
    • Cybin (AMEX:CYBN) stock hit $0.35 on Friday morning, setting a new 52-week low for a change of down 0.52%.
    • BM Technologies (AMEX:BMTX) shares were up 0.04% for the day, having made a 52-week low of $4.99.
    • Equillium (NASDAQ:EQ) shares hit a yearly low of $1.55. The stock was down 3.13% on the session.
    • SQZ Biotechnologies (NYSE:SQZ) shares moved down 8.34% on Friday to hit a new 52-week low of $1.63, drifting down 8.34%.
    • Lightning eMotors (NYSE:ZEV) stock set a new 52-week low of $0.54 on Friday, moving down 5.35%.
    • New York City REIT (NYSE:NYC) stock set a new 52-week low of $2.10 on Friday, moving down 3.51%.
    • Senstar Tech (NASDAQ:SNT) shares set a new yearly low of $1.38 this morning. The stock was down 1.43% on the session.
    • Boxlight (NASDAQ:BOXL) stock hit $0.38 on Friday morning, setting a new 52-week low for a change of down 2.28%.
    • Rockley Photonics Hldgs (NYSE:RKLY) shares were up 2.22% for the day, having made a 52-week low of $0.20.
    • Charles & Colvard (NASDAQ:CTHR) stock drifted 0.0% (flat) on Friday morning to hit a new 52-week low of $0.87.
    • Golden Sun Education Gr (NASDAQ:GSUN) stock broke to a new 52-week low of $1.35 on Friday. Shares of the company traded down 5.52%.
    • Dolphin Entertainment (NASDAQ:DLPN) shares reached a new 52-week low of $2.31 on Friday morning, moving 0.0% (flat).
    • Stronghold Digital Mining (NASDAQ:SDIG) stock hit a new 52-week low of $0.68. The stock was up 2.15% on the session.
    • Rubius Therapeutics (NASDAQ:RUBY) shares hit a yearly low of $0.20. The stock was up 2.58% on the session.
    • China Natural Resources (NASDAQ:CHNR) stock broke to a new 52-week low of $0.38 on Friday. Shares of the company traded up 4.97%.
    • Ecoark Hldgs (NASDAQ:ZEST) shares hit a yearly low of $0.58. The stock was up 0.02% on the session.
    • Blue Star Foods (NASDAQ:BSFC) shares set a new yearly low of $0.53 this morning. The stock was down 4.48% on the session.
    • Genius Gr (AMEX:GNS) stock set a new 52-week low of $0.42 on Friday, moving up 0.24%.
    • Laird Superfood (AMEX:LSF) stock hit a yearly low of $1.07. The stock was down 3.57% for the day.
    • Harbor Custom Dev (NASDAQ:HCDI) stock dropped to a yearly low on Friday of $0.58. Shares traded up 0.37%.
    • Akanda (NASDAQ:AKAN) stock drifted down 10.34% on Friday morning to hit a new 52-week low of $0.19.
    • Viveve Medical (NASDAQ:VIVE) stock dropped to a yearly low on Friday of $0.39. Shares traded up 0.26%.
    • CNS Pharmaceuticals (NASDAQ:CNSP) shares reached a new 52-week low of $2.80 on Friday morning, moving up 0.52%.

    Be sure to monitor Benzinga for the news traders need! And for even more up-to-date info on 52-week lows and highs, check out Benzinga Pro. This cutting-edge market research platform alerts traders of which stocks are trading near their 52-week highs and lows each morning - and delivers lots of other actionable data. Learn more here.

    Get the next $AIP alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AIP
    $AKAN
    $ASAN
    $ATIP

    CompanyDatePrice TargetRatingAnalyst
    Stoke Therapeutics Inc.
    $STOK
    2/5/2026$60.00Buy
    Guggenheim
    Relmada Therapeutics Inc.
    $RLMD
    1/23/2026$8.00Outperform
    Leerink Partners
    Sally Beauty Holdings Inc. (Name to be changed from Sally Hold
    $SBH
    1/21/2026$19.00Mkt Perform → Outperform
    Raymond James
    Asana Inc.
    $ASAN
    1/15/2026$16.00Neutral → Buy
    Citigroup
    Sally Beauty Holdings Inc. (Name to be changed from Sally Hold
    $SBH
    1/14/2026$16.00Buy → Hold
    Jefferies
    Instil Bio Inc.
    $TIL
    1/7/2026Buy → Neutral
    H.C. Wainwright
    Instil Bio Inc.
    $TIL
    1/6/2026$7.00Outperform → Neutral
    Robert W. Baird
    Stoke Therapeutics Inc.
    $STOK
    1/5/2026$35.00Buy
    Chardan Capital Markets
    More analyst ratings

    $AIP
    $AKAN
    $ASAN
    $ATIP
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Guggenheim initiated coverage on Stoke Therapeutics with a new price target

    Guggenheim initiated coverage of Stoke Therapeutics with a rating of Buy and set a new price target of $60.00

    2/5/26 6:58:02 AM ET
    $STOK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Leerink Partners resumed coverage on Relmada Therapeutics with a new price target

    Leerink Partners resumed coverage of Relmada Therapeutics with a rating of Outperform and set a new price target of $8.00

    1/23/26 8:21:07 AM ET
    $RLMD
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Sally Beauty upgraded by Raymond James with a new price target

    Raymond James upgraded Sally Beauty from Mkt Perform to Outperform and set a new price target of $19.00

    1/21/26 8:30:43 AM ET
    $SBH
    Other Specialty Stores
    Consumer Discretionary

    $AIP
    $AKAN
    $ASAN
    $ATIP
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Schorsch Nicholas S bought $19,269 worth of shares (1,664 units at $11.58) (SEC Form 4)

    4 - American Strategic Investment Co. (0001595527) (Issuer)

    2/2/26 9:31:35 PM ET
    $NYC
    Real Estate Investment Trusts
    Real Estate

    Chief Executive Officer O'Dowd William Iv bought $4,872 worth of shares (2,900 units at $1.68), increasing direct ownership by 0.68% to 431,690 units (SEC Form 4)

    4 - Dolphin Entertainment, Inc. (0001282224) (Issuer)

    2/2/26 5:25:10 PM ET
    $DLPN
    Other Consumer Services
    Consumer Discretionary

    Large owner Schorsch Nicholas S bought $55,594 worth of shares (4,992 units at $11.14) (SEC Form 4)

    4 - American Strategic Investment Co. (0001595527) (Issuer)

    1/29/26 9:11:35 PM ET
    $NYC
    Real Estate Investment Trusts
    Real Estate

    $AIP
    $AKAN
    $ASAN
    $ATIP
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    B&G Foods Announces Tax Treatment of Common Stock Dividends Paid in 2025

    B&G Foods, Inc. (NYSE:BGS) today explained the tax treatment for dividends paid in 2025 on the Company's common stock. Holders are urged to check their 2025 tax statements received from brokerage firms to ensure that the cash distribution information reported on such statements conforms to the information reported herein. Additional information concerning the tax treatment of dividends paid in 2025 is posted to the Investors section of B&G Foods' website, www.bgfoods.com, under the headings "FAQs" and "IRS Form 8937." Holders are also urged to consult their own tax advisors to determine their individual tax treatment. In 2025, B&G Foods distributed $0.76000 per share of common stock (CU

    2/6/26 5:30:00 PM ET
    $BGS
    Packaged Foods
    Consumer Staples

    Del Monte Foods Receives Court Approval for Sale Transactions

    Court approves asset purchase agreements across all Del Monte Foods business segments, including Vegetable, Fruit, Tomato, and Broth & Stock businesses Provides a clear path forward for Del Monte Foods' portfolio of brands and businesses under new ownership Company remains focused on maintaining service continuity for customers and partners through close of transactions WALNUT CREEK, Calif., Feb. 6, 2026 /PRNewswire/ -- Del Monte Foods Corporation II Inc. (the "Company" or "Del Monte Foods"), a leading producer, distributor, and marketer of premium quality, packaged food products, today announced that it has received Court approval for three asset purchase agreements (the "Sale Transactions

    2/6/26 3:11:00 PM ET
    $BGS
    $FDP
    Packaged Foods
    Consumer Staples
    Farming/Seeds/Milling

    Stoke Therapeutics to Present at the Guggenheim Emerging Outlook: Biotech Summit 2026

    Stoke Therapeutics, Inc. (NASDAQ:STOK) is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine and has a lead investigational medicine, zorevunersen, in development as a first-in-class potential disease-modifying treatment for Dravet syndrome. Today, the Company announced that Chief Executive Officer Ian F. Smith will present at the Guggenheim Emerging Outlook: Biotech Summit 2026 on Wednesday, February 11, 2026, at 2:30 p.m. ET. A live audio webcast of the presentation, along with an archived replay, will be available in the Investors & News section of Stoke's website at https://investor.stoketherapeutics.com/. About Sto

    2/4/26 4:01:00 PM ET
    $BIIB
    $STOK
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations

    $AIP
    $AKAN
    $ASAN
    $ATIP
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Innovator Hamilton Laird exercised 50,000 shares at a strike of $2.00, increasing direct ownership by 5% to 1,005,927 units (SEC Form 4)

    4 - Laird Superfood, Inc. (0001650696) (Issuer)

    2/5/26 6:17:46 PM ET
    $LSF
    Packaged Foods
    Consumer Staples

    Director Walsh Kenneth M sold $224,721 worth of shares (10,000 units at $22.47), decreasing direct ownership by 10% to 92,260 units (SEC Form 4)

    4 - Eagle Bancorp Montana, Inc. (0001478454) (Issuer)

    2/5/26 12:49:03 PM ET
    $EBMT
    Major Banks
    Finance

    Director Cohler Matt was granted 823 shares, increasing direct ownership by 0.24% to 339,849 units (SEC Form 4)

    4 - Asana, Inc. (0001477720) (Issuer)

    2/4/26 6:02:27 PM ET
    $ASAN
    Computer Software: Prepackaged Software
    Technology

    $AIP
    $AKAN
    $ASAN
    $ATIP
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    August 30, 2024 - La FDA autoriza la vacuna contra el COVID-19 de Novavax actualizada para brindar una mejor protección contra las variantes que circulan actualmente.

    For Immediate Release: August 30, 2024 English Hoy, la Administración de Alimentos y Medicamentos de los Estados Unidos (FDA, por sus siglas en inglés) otorgó una autorización de uso de emergencia (EUA, por sus siglas en inglés) para una versión actualizada de la vacuna contra el COVID-19 de Novavax que ataca más de cerca a las variantes que circulan actualmente para brindar una mejor protección contra las cons

    9/3/24 2:26:49 PM ET
    $NVAX
    $PFE
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations

    August 30, 2024 - FDA Authorizes Updated Novavax COVID-19 Vaccine to Better Protect Against Currently Circulating Variants

    For Immediate Release: August 30, 2024 Today, the U.S. Food and Drug Administration granted emergency use authorization (EUA) for an updated version of the Novavax COVID-19 vaccine that more closely targets currently circulating variants to provide better protection against serious consequences of COVID-19, including hospitalization and death. The updated vaccine is authorized for use in individuals 12 years of

    8/30/24 2:26:48 PM ET
    $NVAX
    $PFE
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations

    October 3, 2023 - FDA Authorizes Updated Novavax COVID-19 Vaccine Formulated to Better Protect Against Currently Circulating Variants

    For Immediate Release: October 03, 2023 Today, the U.S. Food and Drug Administration amended the emergency use authorization (EUA) of the Novavax COVID-19 Vaccine, Adjuvanted for use in individuals 12 years of age and older to include the 2023-2024 formula. Individuals 12 years of age and older previously vaccinated with a COVID-19 vaccine (and who have not already been vaccinated with a recently updated mRNA CO

    10/3/23 2:56:27 PM ET
    $NVAX
    $PFE
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations

    $AIP
    $AKAN
    $ASAN
    $ATIP
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13G/A filed by Equillium Inc.

    SCHEDULE 13G/A - Equillium, Inc. (0001746466) (Subject)

    2/6/26 4:32:05 PM ET
    $EQ
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form SCHEDULE 13G filed by Relmada Therapeutics Inc.

    SCHEDULE 13G - RELMADA THERAPEUTICS, INC. (0001553643) (Subject)

    2/6/26 4:31:51 PM ET
    $RLMD
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 6-K filed by Genius Group Limited

    6-K - Genius Group Ltd (0001847806) (Filer)

    2/6/26 9:00:18 AM ET
    $GNS
    Services-Misc. Amusement & Recreation
    Consumer Discretionary

    $AIP
    $AKAN
    $ASAN
    $ATIP
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by ATI Physical Therapy Inc.

    SC 13D/A - ATI Physical Therapy, Inc. (0001815849) (Subject)

    12/17/24 5:51:04 PM ET
    $ATIP
    Hospital/Nursing Management
    Health Care

    Amendment: SEC Form SC 13D/A filed by ModivCare Inc.

    SC 13D/A - ModivCare Inc (0001220754) (Subject)

    12/13/24 9:05:42 PM ET
    $MODV
    Transportation Services
    Consumer Discretionary

    Amendment: SEC Form SC 13D/A filed by ModivCare Inc.

    SC 13D/A - ModivCare Inc (0001220754) (Subject)

    12/13/24 5:07:48 PM ET
    $MODV
    Transportation Services
    Consumer Discretionary

    $AIP
    $AKAN
    $ASAN
    $ATIP
    Leadership Updates

    Live Leadership Updates

    View All

    Cinch Home Services Welcomes Digital Transformation Leader Kristine Miller to its Board of Advisors

    BOCA RATON, Fla., Jan. 22, 2026 /PRNewswire/ -- Cinch Home Services today announced the appointment of Kristine (Kris) Miller to its Board of Advisors. Miller is a highly regarded digital, strategy, and transformation leader with more than two decades of experience helping organizations modernize, scale, and deliver customer-centered growth across complex, consumer-facing businesses. As a member of the Board, she will help guide Cinch Home Services' strategic direction as the company continues to expand its mission of simplifying home ownership through innovative and reliable home protection solutions. 

    1/22/26 1:00:00 PM ET
    $GROV
    Catalog/Specialty Distribution
    Consumer Discretionary

    Sify reports Consolidated Financial Results for Q3 FY 2025-26

    Revenues of INR 11596 Million. EBITDA of INR 2470 Million. Loss for the period INR 329 Million. CHENNAI, India, Jan. 12, 2026 (GLOBE NEWSWIRE) -- DETAILS OF EARNING CALL         January 13, 2026 | 8:30 AM ET | 07:00 PM IST Participant Dial in: To join: +1-888-506-0062 (Toll Free in the U.S. or Canada) or +1-973-528-0011 (International) | Access Code: 910873 On the call: Mr. Raju Vegesna, Chairman of the Board and Mr. M P Vijay Kumar, Executive Director & Group CFO Live webcast: https://www.webcaster4.com/Webcast/Page/2184/53449. Archives: +1-877-481-4010 (Toll Free in the U.S. or Canada) or +1-919-882-2331 (International). Passcode 53449 Replay is available unti

    1/12/26 8:45:23 AM ET
    $SIFY
    Computer Software: Programming Data Processing
    Technology

    B&G Foods Appoints John Ozgopoyan as Executive Vice President of Sales

    B&G Foods, Inc. (NYSE:BGS) announced that effective today it has hired John Ozgopoyan as Executive Vice President of Sales. As a member of B&G Foods' executive leadership team, Mr. Ozgopoyan will report directly to Casey Keller, President and Chief Executive Officer. Commenting on Mr. Ozgopoyan's hire, Mr. Keller stated, "John is an experienced sales executive who develops strong relationships with customers. We are excited to bring John's sales leadership, customer development and sales execution skills to B&G Foods as we continue to sharpen our focus on our core brands and improving our base business net sales." Most recently, Mr. Ozgopoyan served as Chief Customer Officer – North Ame

    1/5/26 4:34:00 PM ET
    $BGS
    Packaged Foods
    Consumer Staples

    $AIP
    $AKAN
    $ASAN
    $ATIP
    Financials

    Live finance-specific insights

    View All

    B&G Foods Announces Tax Treatment of Common Stock Dividends Paid in 2025

    B&G Foods, Inc. (NYSE:BGS) today explained the tax treatment for dividends paid in 2025 on the Company's common stock. Holders are urged to check their 2025 tax statements received from brokerage firms to ensure that the cash distribution information reported on such statements conforms to the information reported herein. Additional information concerning the tax treatment of dividends paid in 2025 is posted to the Investors section of B&G Foods' website, www.bgfoods.com, under the headings "FAQs" and "IRS Form 8937." Holders are also urged to consult their own tax advisors to determine their individual tax treatment. In 2025, B&G Foods distributed $0.76000 per share of common stock (CU

    2/6/26 5:30:00 PM ET
    $BGS
    Packaged Foods
    Consumer Staples

    NGL Energy Partners LP Announces Third Quarter Fiscal 2026 Financial Results

    NGL Energy Partners LP (NYSE:NGL) ("NGL," "we," "us," "our," or the "Partnership") today reported its third quarter Fiscal 2026 financial results. Highlights include: Financial Results: Income from continuing operations for the third quarter of Fiscal 2026 of $48.2 million, compared to income from continuing operations of $23.7 million for the third quarter of Fiscal 2025 Adjusted EBITDA from continuing operations(1) for the third quarter of Fiscal 2026 of $172.5 million, compared to $158.0 million for the third quarter of Fiscal 2025 Water Solutions Volumes: Record produced water volumes physically disposed of approximately 3.07 million barrels per day during the third quarte

    2/3/26 4:31:00 PM ET
    $NGL
    Natural Gas Distribution
    Utilities

    Arteris to Announce Financial Results for the Fourth Quarter and Year End 2025 on Thursday, February 12, 2026

    CAMPBELL, Calif., Feb. 02, 2026 (GLOBE NEWSWIRE) -- Arteris, Inc. (NASDAQ:AIP), a leading technology provider for accelerating semiconductor creation in the AI era, today announced it will release its financial results for the fourth quarter and full year ended December 31, 2025, after market close on Thursday, February 12, 2026. Management will host a conference call on Thursday, February 12, 2026, at 4:30 PM ET to discuss these results. The call will be available, live, to interested parties by dialing: United States/Canada Toll Free:+1-800-717-1738International Toll:+1-646-307-1865 Please join the call 5-10 minutes prior to the scheduled start time to avoid a delay in connecting. A liv

    2/2/26 4:05:00 PM ET
    $AIP
    Semiconductors
    Technology